A Study to Evaluate Clinical Benefit, Performance and Safety of Cochlear Implants in Adults
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Cochlear
- Trial code
- NCT07338864
- Record updated
- 22 October 2026
- Original description
The aim of this clinical investigation is to demonstrate the performance, clinical benefit and safety of commercial cochlear implant systems. Speech performance and subjective hearing results, and comparison with cochlear implant results available in literature, is intended to demonstrate the performance and clinical benefit of the cochlear implant systems investigated in this study.Read full original descriptionShow less
A Post-market, Prospective, Observational Study to Evaluate Clinical Benefit, Performance and Safety of Cochlear™ Implants in an Adult Population: a Master Umbrella Investigation
The aim of this clinical investigation is to demonstrate the performance, clinical benefit and safety of commercial cochlear implant systems. Speech performance and subjective hearing results, and comparison with cochlear implant results available in literature, is intended to demonstrate the performance and clinical benefit of the cochlear implant systems investigated in this study.
Inclusion: Aged 18 years or older (at time of consent); Clinically established post-linguistic moderately severe to profound sensorineural hearing loss, in the ear to be implanted; Compromised functional hearing with hearing aid(s) or unlikely to receive benefit with hearing aid(s) in the ear to be implanted; Cochlear implant candidate as determined by the Principal Investigator. Meets local candidacy criteria for cochlear implantation; Candidate is a fluent speaker in the language used to assess speech perception performance; Willing and able to comply with study follow-up schedule; Willing and able to provide written informed consent; Candidate has access to a Smartphone compatible with Nucleus Smart App.
Exclusion: Prior cochlear implantation in the ear to be implanted; Unrealistic expectations regarding the possible benefit, risks and limitations that are inherent to the surgical procedure and prosthetic device as determined by the investigator; Current participation, or participation in an interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless Cochlear sponsored and determined by Investigator or Sponsor to not impact this investigation); Any contraindications for cochlear implantation listed in the relevant product physician's guide (to be specified per sub-investigation); Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator; Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as spouse, parent, child or sibling; Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation; Women who are pregnant.